Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Arix Bioscience plc
  6. Company
    ARIX   GB00BD045071

ARIX BIOSCIENCE PLC

(ARIX)
  Report
Delayed Quote. Delayed London Stock Exchange - 08/05 03:04:32 am
175 GBX   -1.13%
08/02Transaction in own shares
DJ
08/02Total Voting Rights
DJ
07/30Transaction in own shares
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Arix Bioscience plc is a United Kingdom-based healthcare and life science company. The Company is a holding company that is focused on generating value from the development and commercialization of technologies and discoveries. Its principal activity is to source, finance and develop healthcare and life science businesses across the world. The Company focuses on acquiring interests in, and provide operational oversight to, healthcare and life science businesses with which it partners in the healthcare and life science sector. The Company holds interests in BioMotiv, OptiKira LLC, Autolus, Depixus SAS, Verona Pharma plc and Artios Pharma Ltd. The Company has agreements with universities in the United Kingdom, Europe and Australia, providing direct access to new technologies. It also has access to a range of research projects from the United States academic institutions. Its subsidiaries include Arix Bioscience Holdings Limited, Arix US Inc and Arthurian Life Sciences GP Limited.
Sales per Business
20192020Delta
Healthcare and Life Science0.51100%0.48100% -5.73%
GBP in Million
Sales per region
20192020Delta
United Kingdom0.51100%0.48100% -5.73%
GBP in Million
Managers
Name Title Age Since
Robert William Henry Lyne CEO, COO, Secretary, Director & General Counsel 37 2021
Marcus Karia Group Finance Director - 2019
Graeme Smith, Dr. Chief Technology Officer - 2017
Charlotte Parry Head-Investor Relations - 2018
Christian Schetter, Dr. Managing Director 57 -
Mark Chin Managing Director 38 2021
Michelle Keating Financial Controller - 2020
Members of the board
Name Title Age Since
Peregrine D. E. M. Moncreiffe Non-Executive Chairman 69 2021
Robert William Henry Lyne CEO, COO, Secretary, Director & General Counsel 37 2021
Giles Francis Bertram Kerr Non-Executive Director 61 2017
Maureen E. O'Connell Non-Executive Director 59 2021
Isaac Theodore Kohlberg Non-Executive Director 69 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 130,828,800 94,601,721 72.3% 0 0.0% 72.3%
Stock B 0 49,671 0 0.0% 0 0.0%
Shareholders
NameEquities%
Link Fund Solutions Ltd. 26,819,617 20.4%
Fosun International Limited 11,111,111 8.46%
Ruffer LLP 8,180,878 6.23%
Takeda Ventures, Inc. 7,497,583 5.71%
Christopher Chipperton 6,862,823 5.23%
Ipsen S.A. 6,666,666 5.08%
Christopher Thomas Evans 5,866,039 4.47%
UCB SA 5,647,679 4.30%
Jupiter Asset Management Ltd. 3,238,798 2.47%
Handelsbanken Wealth & Asset Management Ltd. 1,960,392 1.49%
Holdings
NameEquities%Valuation
HARPOON THERAPEUTICS, INC. (HARP) 2,190,922 6.74% 30,388,088 USD
IMARA INC. (IMRA) 2,344,072 8.97% 18,518,169 USD
AUTOLUS THERAPEUTICS PLC 2,736,533 5.24% 18,170,579 USD
LOGICBIO THERAPEUTICS, INC. (LOGC) 2,381,436 7.40% 10,573,576 USD
ITERUM THERAPEUTICS PLC (ITRM) 329,193 0.18% 760,436 USD
Sector Other Holding Companies
1st jan.Capi. (M$)
ARIX BIOSCIENCE PLC-19.18%309
INVESTOR AB (PUBL)45.27%77 401
CK HUTCHISON HOLDINGS LIMITED4.16%27 888
AB INDUSTRIVÄRDEN (PUBL)28.74%17 525
HAL TRUST29.70%15 323
LIFCO AB (PUBL)64.77%13 685
KINNEVIK AB92.68%12 985
KINGDOM HOLDING COMPANY35.85%10 673
BRADESPAR S.A.13.92%4 809
REMGRO LIMITED17.36%4 411
BIN DAWOOD HOLDING COMPANY-9.75%3 274
COMPASS DIVERSIFIED29.82%1 639
ITALMOBILIARE S.P.A.7.85%1 581
V-ZUG HOLDING AG55.61%973
INTEGRATED HOLDING COMPANY K.S.C.P.16.57%312
2INVEST AG608.79%88